Skip to main content
Header image

Anticancer effect of zanubrutinib in HER2-positive breast cancer cell lines

Anticancer effect of zanubrutinib in HER2-positive breast cancer cell lines. Investigational New Drugs. 2023, 41(2), 210-219, ISSN: 0167-6997, PMID: 36913160,